Free Trial

Corcept Therapeutics (CORT) Competitors

Corcept Therapeutics logo
$69.68 +1.53 (+2.24%)
As of 12:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CORT vs. ANVS, RPRX, JAZZ, PRGO, SUPN, PCRX, NKTR, OMER, ASMB, and CPIX

Should you be buying Corcept Therapeutics stock or one of its competitors? The main competitors of Corcept Therapeutics include Annovis Bio (ANVS), Royalty Pharma (RPRX), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Supernus Pharmaceuticals (SUPN), Pacira BioSciences (PCRX), Nektar Therapeutics (NKTR), Omeros (OMER), Assembly Biosciences (ASMB), and Cumberland Pharmaceuticals (CPIX). These companies are all part of the "medical" sector.

Corcept Therapeutics vs. Its Competitors

Corcept Therapeutics (NASDAQ:CORT) and Annovis Bio (NYSE:ANVS) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings.

Corcept Therapeutics has a net margin of 19.33% compared to Annovis Bio's net margin of 0.00%. Corcept Therapeutics' return on equity of 20.40% beat Annovis Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Corcept Therapeutics19.33% 20.40% 16.64%
Annovis Bio N/A -300.56%-193.50%

Corcept Therapeutics has higher revenue and earnings than Annovis Bio. Annovis Bio is trading at a lower price-to-earnings ratio than Corcept Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Corcept Therapeutics$685.45M10.78$141.21M$1.1660.07
Annovis BioN/AN/A-$24.59M-$2.16-1.26

In the previous week, Corcept Therapeutics had 20 more articles in the media than Annovis Bio. MarketBeat recorded 21 mentions for Corcept Therapeutics and 1 mentions for Annovis Bio. Corcept Therapeutics' average media sentiment score of 0.90 beat Annovis Bio's score of 0.00 indicating that Corcept Therapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Corcept Therapeutics
11 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Annovis Bio
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Corcept Therapeutics presently has a consensus target price of $138.25, suggesting a potential upside of 98.39%. Annovis Bio has a consensus target price of $18.00, suggesting a potential upside of 562.98%. Given Annovis Bio's higher possible upside, analysts plainly believe Annovis Bio is more favorable than Corcept Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Corcept Therapeutics
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
Annovis Bio
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.00

93.6% of Corcept Therapeutics shares are held by institutional investors. Comparatively, 15.8% of Annovis Bio shares are held by institutional investors. 20.8% of Corcept Therapeutics shares are held by insiders. Comparatively, 20.8% of Annovis Bio shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Corcept Therapeutics has a beta of 0.15, suggesting that its share price is 85% less volatile than the S&P 500. Comparatively, Annovis Bio has a beta of 1.57, suggesting that its share price is 57% more volatile than the S&P 500.

Summary

Corcept Therapeutics beats Annovis Bio on 11 of the 15 factors compared between the two stocks.

Get Corcept Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CORT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CORT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CORT vs. The Competition

MetricCorcept TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$7.40B$2.70B$5.53B$8.98B
Dividend YieldN/A1.79%5.25%4.04%
P/E Ratio60.129.1627.0720.16
Price / Sales10.78756.20430.62124.91
Price / Cash54.38159.8036.8257.86
Price / Book10.744.608.075.57
Net Income$141.21M$31.26M$3.17B$248.52M
7 Day Performance-2.32%6.61%3.91%5.05%
1 Month Performance-1.25%3.75%3.63%6.98%
1 Year Performance133.06%3.11%34.00%21.36%

Corcept Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CORT
Corcept Therapeutics
4.6905 of 5 stars
$69.69
+2.2%
$138.25
+98.4%
+131.0%$7.40B$685.45M60.12300
ANVS
Annovis Bio
1.6462 of 5 stars
$2.18
+6.3%
$30.25
+1,287.6%
-83.6%$42.49MN/A-1.013
RPRX
Royalty Pharma
4.8861 of 5 stars
$36.03
+0.4%
$47.33
+31.4%
+38.1%$20.26B$2.26B19.4880Positive News
JAZZ
Jazz Pharmaceuticals
4.8937 of 5 stars
$106.12
-0.7%
$184.00
+73.4%
+8.4%$6.42B$4.07B14.152,800
PRGO
Perrigo
4.8429 of 5 stars
$26.73
+0.7%
$33.00
+23.5%
+5.6%$3.67B$4.37B-20.408,379
SUPN
Supernus Pharmaceuticals
2.8416 of 5 stars
$31.52
+1.2%
$36.00
+14.2%
+22.3%$1.76B$661.82M28.40580
PCRX
Pacira BioSciences
3.4329 of 5 stars
$23.90
+1.8%
$26.44
+10.6%
+12.5%$1.11B$702.77M-10.48720
NKTR
Nektar Therapeutics
4.8111 of 5 stars
$25.84
+0.3%
$84.17
+225.7%
+22.2%$320.67M$98.43M-2.69220Analyst Forecast
Gap Up
High Trading Volume
OMER
Omeros
3.2764 of 5 stars
$3.00
-6.3%
$18.00
+500.0%
-19.5%$175.77MN/A-1.13210
ASMB
Assembly Biosciences
3.7657 of 5 stars
$18.12
+4.7%
$33.00
+82.1%
+30.6%$138.44M$28.52M-2.91100Trending News
High Trading Volume
CPIX
Cumberland Pharmaceuticals
0.5937 of 5 stars
$3.35
+28.8%
N/A+107.4%$50.12M$37.87M-13.4080News Coverage

Related Companies and Tools


This page (NASDAQ:CORT) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners